Table 2. Correlative analysis of clinical trial endpoints supporting approval of investigational agents for NSCLC.
Abbreviations: BSC, best supportive care; NSCLC, non‐small cell lung cancer; ORR, objective response rate; OS, overall survival; PFS, progression‐free survival.